Electrophysiological actions of peripheral hormones on melanocortin neurons

Annals of the New York Academy of Sciences

Volumn 994, Issue , 2003, Pages 175-186

  Cowley, Michael A ^a   Cone, Roger D ^b   Enriori, Pablo ^a   Louiselle, Ingrid ^a   Williams, Sarah M ^a   Evans, Anne E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Agouti related peptide (AgRP); Electrophysiology; Energy homeostasis; Food intake; Gut; Hypothalamus; Neuropeptide Y (NPY); Neuropeptides; Pro opiomelanocortin (POMC); Transgene

Indexed keywords

4 AMINOBUTYRIC ACID; AGOUTI RELATED PROTEIN; FENFLURAMINE; GASTROINTESTINAL HORMONE; GHRELIN; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN; NEUROPEPTIDE; NEUROPEPTIDE Y; PEPTIDE YY; PEPTIDE YY[3-36]; PROOPIOMELANOCORTIN; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

APPETITE; ARCUATE NUCLEUS; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; BRAIN STEM; CELL TYPE; CONFERENCE PAPER; DRUG MECHANISM; ENERGY BALANCE; FOOD INTAKE; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE IDENTIFICATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS; METABOLIC DISORDER; MODEL; NERVE CELL; NERVE PROJECTION; NERVE TRACT; NEUROMODULATION; NEUROSECRETORY CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; NUTRITIONAL STATUS; RAPHE NUCLEUS; SEROTONINERGIC NERVE CELL; TRANSGENE; TRANSGENIC MOUSE;

AGOUTI; MUS MUSCULUS;

EID: 0037713312     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03178.x     Document Type: Conference Paper

References (67)

1. PEETERS, A. et al. 2003. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern. Med. 138: 24-32.
2. FONTAINE, K.R. et al. 2003. Years of life lost due to obesity. J. Am. Med. Assoc. 289: 187-193.
3. MOKDAD, A.H. et al. 2001. The continuing epidemics of obesity and diabetes in the United States. J. Am. Med. Assoc. 286: 1195-1200.
4. HETHERINGTON, A.W. & S.W. RANSON. 1940. Hypothalamic lesions and obesity on the rat. Anat. Rec. 78: 149-172.
5. CONE, R.D. et al. 2001. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 25(Suppl 5): S63-S67.
6. SPIEGELMAN, B.M. & J.S. FLIER. 2001. Obesity and the regulation of energy balance. Cell 104: 531-543.
7. ZHANG, Y. et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
8. TARTAGLIA, L.A. et al. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271.
9. CHUA, S.C., JR. et al. 1996. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor [see comments]. Science 271: 994-996.
10. CHUA, S.C., JR. et al. 1997. Fine structure of the murine leptin receptor gene: Splice site suppression is required to form two alternatively spliced transcripts. Genomics 45: 264-270.
11. EMILSSON, V. et al. 1997. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46: 313-316.
12. ELMQUIST, J.K. et al. 1998. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 395: 535-547.
13. FEI, H. et al. 1997. Anatomic localization of alternatively spliced leptin receptors (ObR) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA 94: 7001-7005.
14. ELMQUIST, J.K. et al. 1998. Unraveling the central nervous system pathways underlying responses to leptin. Nat. Neurosci. 1: 445-450.
15. LEE, G.H. et al. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
16. CHEN, H. et al. 1996. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495.
17. MERCER, J.G. et al. 1996. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387: 113-116.
18. SCHWARTZ, M.W. et al. 1996. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98: 1101-1106.
19. MERCER, J.G. et al. 1996. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J. Neuroendocrinol. 8: 733-735.
20. BANKS, W.A. et al. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305-311.
21. BJORBAEK, C. et al. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1: 619-625.
22. ELIAS, C.F. et al. 1999. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23: 775-786.
23. CHEUNG, C.C., D.K. CLIFTON & R.A. STEINER. 1997. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138: 4489-4492.
24. HAKANSSON, M.L., A.L. HULTING & B. MEISTER. 1996. Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus - relationship with NPY neurones. Neuroreport 7: 3087-3092.
25. KALRA, S.P. et al. 1999. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20: 68-100.
26. BILLINGTON, C.J. et al. 1991. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 260: R321-R327.
27. STANLEY, B.G., A.S. CHIN & S.F. LEIBOWITZ. 1985. Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res. Bull. 14: 521-524.
28. STEPHENS, T.W. et al. 1995. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532.
29. ERICKSON, J.C., G. HOLLOPETER & R.D. PALMITER. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274: 1704-1707.
30. INUI, A. 1999. Neuropeptide Y: A key molecule in anorexia and cachexia in wasting disorders? Mol. Med. Today 5: 79-85.
31. BROBERGER, C. et al. 1998. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. USA 95: 15043-15048.
32. MIZUNO, T.M. & C.V. MOBBS. 1999. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140: 814-817.
33. SHUTTER, J.R. et al. 1997. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11: 593-602.
34. THORNTON, J.E. et al. 1997. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138: 5063-5066.
35. WILDING, J.P. et al. 1993. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132: 1939-1944.
36. BULTMAN, S.J., E.J. MICHAUD & R.P. WOYCHIK. 1992. Molecular characterization of the mouse agouti locus. Cell 71: 1195-1204.
37. FAN, W. et al. 1997. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168.
38. LU, D. et al. 1994. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371: 799-802.
39. HUSZAR, D. et al. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141.
40. FONG, T.M. et al. 1997. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Res. Commun. 237: 629-631.
41. OLLMANN, M.M. et al. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138.
42. WOODS, A.J. & M.J. STOCK. 1996. Leptin activation in hypothalamus. Nature 381: 745.
43. KIM, M.S. et al. 2000. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J. Clin. Invest. 105: 1005-1011.
44. POWIS, J.E., J.S. BAINS & A.V. FERGUSON. 1998. Leptin depolarizes rat hypothalamic paraventricular nucleus neurons. Am. J. Physiol. 274: R1468-R1472.
45. HAYNES, W.G. et al. 1997. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 100: 270-278.
46. GLAUM, S.R. et al. 1996. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol. Pharmacol. 50: 230-235.
47. SPANSWICK, D. et al. 1997. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390: 521-525.
48. SHIRAISHI, T. et al. 1999. Leptin effects on feeding-related hypothalamic and peripheral neuronal activities in normal and obese rats. Nutrition 15: 576-579.
49. + channels in hypothalamic neurons of lean, but not obese rats. Nat. Neurosci. 3: 757-758.
50. LEVIN, B.E., A.A. DUNN-MEYNELL & V. H. ROUTH. 1999. Brain glucose sensing and body energy homeostasis: Role in obesity and diabetes. Am. J. Physiol. 276: R1223-R1231.
51. LEVIN, B.E., A.A. DUNN-MEYNELL & V.H. ROUTH. 2001. Brain glucosensing and the K(ATP) channel. Nat. Neurosci. 4: 459-460.
52. + channels in rat CRI-G1 insulin secreting cells. J. Physiol. 511: 695-706.
53. + channels in the rat insulinoma cell line CRI-G1. J. Physiol. 510: 47-61.
54. + channels in rat CRI-G1 insulin secreting cells. J. Physiol. (Lond.) 511: 695-706.
55. HARVEY, J. et al. 2000. Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line. J. Biol. Chem. 275: 4660-4669.
56. HARVEY, J. et al. 1997. Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1. J. Physiol. (Lond.) 504: 527-535.
57. COWLEY, M.A. et al. 2001. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484.
58. HEISLER, L.K. et al. 2002. Activation of central melanocortin pathways by fenfluramine. Science 297: 609-611.
59. COWLEY, M.A. et al. 1999. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron 24: 155-163.
60. BATTERHAM, R.L. et al. 2002. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654.
61. MARKS, D.L., N. LING & R.D. CONE. 2001. Role of the central melanocortin system in cachexia. Cancer Res. 61: 1432-1438.
62. DORNONVILLE DE LA COUR, C. et al. 2001. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul. Pept. 99: 141-150.
63. KOJIMA, M. et al. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660.
64. CUMMINGS, D.E. et al. 2001. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714-1719.
65. CUMMINGS, D.E. et al. 2002. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346: 1623-1630.
66. COWLEY, M.A. et al. 2003. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 39: 647-661.
67. ARVAT, E. et al. 2001. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 86: 1169-1174.